Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linda Sun

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancerEric H Rubin, Nancy G B Agrawal, Evan J Friedman, et al.
The Lancet. Oncology|September 24, 2013
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind studyMeletios Dimopoulos, David S Siegel, Sagar Lonial, et al.
The Lancet. Oncology|July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trialShahneen K Sandhu, William R Schelman, George Wilding, et al.
Journal of Internal Medicine|January 27, 2025
Multicenter validation of secondary hemophagocytic lymphohistiocytosis diagnostic criteriaGunnar Lachmann, Patrick Heeren, Friederike S Schuster, et al.
Blood|August 28, 2014
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysisAdam M Petrich, Mitul Gandhi, Borko Jovanovic, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 6, 2006
A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancerEric H Rubin, Nancy G B Agrawal, Evan J Friedman, et al.
The Lancet. Oncology|September 24, 2013
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind studyMeletios Dimopoulos, David S Siegel, Sagar Lonial, et al.
The Lancet. Oncology|July 2, 2013
The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trialShahneen K Sandhu, William R Schelman, George Wilding, et al.
Journal of Internal Medicine|January 27, 2025
Multicenter validation of secondary hemophagocytic lymphohistiocytosis diagnostic criteriaGunnar Lachmann, Patrick Heeren, Friederike S Schuster, et al.
Blood|August 28, 2014
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysisAdam M Petrich, Mitul Gandhi, Borko Jovanovic, et al.
Pageof 6